We are live on ! Find out more
FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
1-Year Est. Return 6.87%
This Fund
S&P 500
This Quarter Est. Return
+54.36%
1 Year Est. Return
-6.87%
3 Year Est. Return
+444.07%
5 Year Est. Return
+547.28%
10 Year Est. Return
AUM
$37.9M
AUM Growth
+$10.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$17.1B
$13.8M 36.44%
133,691
VRNA
2
DELISTED
Verona Pharma
VRNA
$11.4M 29.98%
1,111,112
NTRA icon
3
Natera
NTRA
$38.9B
$6.97M 18.41%
159,160
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$5.75M 15.17%
1,641,804

Similar funds

Foresite Capital Management III's Q3 2022 Portfolio in Review

As of Q3 2022, Foresite Capital Management III held 4 positions worth $37.9M, up 37% from $27.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Foresite Capital Management III opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management III's ten largest holdings make up 100% of its $37.9M portfolio in Q3 2022.
  • Foresite Capital Management III opened 0 new positions and closed 0 in Q3 2022.
  • Foresite Capital Management III's portfolio value rose 37% quarter-over-quarter to $37.9M.

Based on Foresite Capital Management III's 13F filing for Q3 2022, filed 14 Nov 2022.